← All stocks

MANNKIND CORP

MNKD Net buying
CIK 0000899460 #2314 in the set updated 17 Sep 2026
Bought (12 mo)
$259.00K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$3.13M
$1.05M on a plan · $2.07M straight out of an exercise
Sold at will
$0.00
0 of 13 sales
Net
−$2.87M
+$259.00K against sales at will

By person

13 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Castagna Michael
Chief Executive Officer
$259.00K (1)
$1.25M (4) scheduled
−$990.29K
2,433,779
0.7569%
$9.27M
+10.4%
Thomson David
EVP Genl Counsel & Secretary
$930.75K (3) scheduled
−$930.75K
797,554
0.2480%
$3.04M
−3.9%
Binder Steven B.
Director
$555.22K (4) scheduled
−$555.22K
752,309
0.2340%
$2.87M
−30.0%
Tross Stuart A
Chief People & Workpl Officer
$297.55K (1) scheduled
−$297.55K
1,058,142
0.3291%
$4.03M
+2.6%
Singh Sanjay R
EVP Technical Operations
$94.45K (1) scheduled
−$94.45K
478,966
0.1490%
$1.82M
+18.4%
BLANK BURKHARD
EVP Chief Medical Officer
460,791
0.1433%
$1.76M
−5.2%
Sabella Lauren M
EVP Operations
349,841
0.1088%
$1.33M
−7.5%
Marasco Dominic
Pres, Endocrine Business Unit
343,398
0.1068%
$1.31M
+6,610%
Prentiss Christopher B
Chief Financial Officer
318,668
0.0991%
$1.21M
+32.4%
Ahuja Ajay
Chief Medical Officer
318,200
0.0990%
$1.21M
HOOPER ANTHONY C
Director
236,153
0.0734%
$899.74K
+34.1%
Consiglio Ronald J
Director
132,342
0.0412%
$504.22K
+8.2%
Shannon James Samuel
Director
64,635
0.0201%
$246.26K
+22.8%
Insider
Date
Role
Action
Shares
Price
Amount
Castagna Michael
10 Mar 2026
Chief Executive Officer
Buy
100,000
$2.59
$259.00K

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,277,932
History held since 31 Aug 2016